Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.
The findings, published today in PLOS Pathogens, are especially important since the microbe, Neisseria gonorrhoeae, is considered a “superbug” because of its resistance to all classes of antibiotics available for treating infections.
Gonorrhea, a sexually transmitted disease that results in 78 million new cases worldwide each year, is highly damaging if untreated or improperly treated.
It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Babies born to infected mothers are at increased risk of blindness.
“The infections very often are silent,” said Oregon State University researcher Aleksandra Sikora. “Up to 50 percent of infected women don’t have symptoms, but those asymptomatic cases can still lead to some very severe consequences for the patient’s reproductive health, miscarriage or premature delivery.”
The need for better antibiotic therapy, and a vaccine, is pressing. N. gonorrhoeae strains resistant to the last effective treatment options have emerged, and failures in treatment are occurring.
Sikora and her research team at the OSU/OHSU College of Pharmacy and Ann Jerse’s lab at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, collaborated to discover a novel lipoprotein that N. gonorrhoeae uses to defeat the body’s first line of innate immune defense.
The body relies on enzymes known as lysozymes that, as their name suggests, thwart bacteria by causing their cell wall to lyse, or break apart. Lysozymes are abundant both in epithelial cells, which make up the tissue on the outside of organs and the inside of body cavities, and in the phagocytic cells that protect the body by ingesting foreign particles and bacteria.
In turn, many gram-negative bacteria – characterized by their cell envelope that includes a protective outer membrane – have developed ways of defeating lysozymes. Prior to the work by Sikora’s team, however, only one lysozyme-fighting protein had been discovered in the Neisseria genus.
Now that new targets have been identified, they can be explored as bullseye candidates for new antibiotics or a vaccine – if the lysozyme inhibitor can itself be inhibited, then the bacteria’s infection-causing ability is greatly reduced.
Sikora and her collaborators named the new protein SliC, short for surface-exposed lysozyme inhibitor of c-type lysozyme.
Studying SliC’s function in culture as well as in a gonorrhea mouse model – mice were infected with N. gonorrhoeae, then checked for SliC expression at one, three and five days – researchers determined the protein was essential to bacterial colonization because of its anti-lysozyme role.
“This is the first time an animal model has been used to demonstrate a lysozyme inhibitor’s role in gonorrhea infection,” Sikora said. “Together, all of our experiments show how important the lysozyme inhibitor is. This is very exciting.”
The Latest on: Gonorrhea
via Google News
The Latest on: Gonorrhea
- What is 'Super Gonorrhea', the infection on rise due to COVID-19on January 9, 2021 at 12:29 am
The overuse of antibiotics in the wake of COVID-19 pandemic has led to a rise in cases of 'super gonorrhea' which may even become incurable. Gonorrhea is a bacterial condition caused by a sexually ...
- WHO warns about the spread of gonorrhea, and failure of antibioticson January 7, 2021 at 4:00 pm
The World Health Organization analyzed data from 77 countries and it showed gonorrhea's resistance to antibiotics was widespread. Dr Teodora Wi from WHO, said “Gonorrhea is a very smart bug ...
- Single-drug regimen now advised for uncomplicated gonorrheaon January 5, 2021 at 10:09 am
(HealthDay)—A single 500-mg intramuscular dose of ceftriaxone is recommended for treatment of uncomplicated urogenital, anorectal, and pharyngeal gonorrhea, according to updated guidelines ...
- What Is Super Gonorrhea? Superbug Not New But Possibly Spreading Because Of COVID-19on December 29, 2020 at 4:12 am
Health authorities have been warning about super gonorrhea for years The COVID-19 pandemic could influence a rise in super gonorrhea cases, an expert said Superbugs are a serious threat to public ...
- Yes, Super Gonorrhea Is Real and It’s Gonna Get Worseon December 29, 2020 at 3:59 am
An illustration of Neisseria gonorrhoeae bacteria, the cause of gonorrhea. (Illustration: Alissa Eckert/CDC) Over the weekend, a particularly awful pair of words started trending on social media ...
- 'Super gonorrhea' may increase in wake of COVID-19 — here’s whyon December 28, 2020 at 3:16 pm
The World Health Organization (WHO) is warning about the potential rise in antibiotic-resistant gonorrhea — also known as “super gonorrhea” — due to overuse of antibiotics during the ...
- Super Gonorrhea May Be Spreading From Antibiotic Overuse For Covid-19 Coronaviruson December 27, 2020 at 2:58 pm
Will the Covid-19 coronavirus lead to much wider spread of drug-resistant gonorrhea in 2021? (Photo ... [+] credit should read FREDERIC J. BROWN/AFP via ) You want 2021 to be super. But not in a super ...
- 'Super Gonorrhea' on the Rise Due to COVID-19, WHO Sayson December 27, 2020 at 1:30 pm
"super gonorrhea," which is getting a COVID assist. The World Health Organization (WHO) told the Sun a mutant, more powerful strain of the burning STD is spreading worldwide ... partly because of ...
- ‘Super Gonorrhea’ is spreading like wildfire thanks to COVID-19on December 23, 2020 at 3:48 pm
Overuse of antibiotics during the coronavirus pandemic has resulted in the more rapid spread of a type of antibiotic-resistant gonorrhea. This so-called ‘Super Gonorrhea’ does not respond to ...
via Bing News